Stream Link:
1pm: https://globalmeet.webcasts.com/starthere.jsp?ei=1702281&tp_key=cf2341bcfa
6pm: https://globalmeet.webcasts.com/starthere.jsp?ei=1702283&tp_key=30918539e8
Program Description
Chronic obstructive pulmonary disease (COPD) is often underdiagnosed and discovered late in the disease's progression, leading to inadequate treatment. Despite COPD being underdiagnosed globally, pharmacists can significantly improve patient outcomes, lower health care costs, and reduce the burden of COPD through early disease identification and timely therapeutic interventions. Pharmacists can improve COPD management through counseling on medication adherence, optimizing medicine delivery, and providing patient-focused treatment. This webinar will review therapies for COPD treatment and guideline-based strategies to ensure personalized management, considering factors such as comorbidities, polypharmacy, and adverse effects. Multidisciplinary strategies to support shared decision-making and adherence to prescribed treatments will be emphasized.
Target audience: Ambulatory care, community, and retail pharmacists
Type of activity: Application
Release date: February 13, 2025
Expiration date: April 13, 2025
Time to complete activity: 1.0 hour
Learner level: Foundational
Fee: Free
Educational Objectives
At the completion of this activity, participants will be able to:
- Analyze current chronic obstructive pulmonary disease (COPD) recommendations and guidelines effectively within clinical practice
- Apply personalized approaches for selecting the most suitable inhaled maintenance treatment for patients with COPD, considering individual symptomatology and risk of exacerbations
- Employ strategies to maintain continuity of care for patients with COPD who are transitioning between inpatient and outpatient settings
Katharine Rimes, PharmD, BCACP, CSP
Clinical Pharmacist
Medication Therapy Management Clinic
UChicago Medicine Advent Health
Bolingbrook, Illinois
Pharmacy Times Continuing Education™ is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 1.0 contact hour (0.10 CEU) under the ACPE universal activity number 0290-0000-25-001-L01-P. The activity is available for CE credit through April 13, 2025.
Instructions for Completing the Activity and Receiving CPE Credit
To receive CPE credit, participants must complete the pretest, review the activity in its entirety, complete the posttest, and complete the online activity evaluation. After successful completion of the online activity evaluation, you can submit your credit to CPE Monitor. You may view your credit within 48 hours at www.mycpemonitor.net. All participants must request credit before the activity expiration date. CE credit will not be issued after this date.
The following contributors have no relevant financial relationships with commercial interests to disclose:
Faculty
Katharine Rimes, PharmD, BCACP, CSP
Pharmacy Times Continuing Education™ Planning Staff—Jim Palatine, RPh, MBA; Maryjo Dixon, RPh, MBA; Dipti Desai, PharmD, MBA, CHCP; Kylie Ferrentino; Susan Pordon; Brianna Winters; Chloe Taccetta; and Rebecca Green
An anonymous peer reviewer was used as part of content validation and conflict resolution. The peer reviewer has no relevant financial relationships with commercial interests to disclose.
Educational Disclaimer
CPE activities are offered solely for educational purposes and do not constitute any form of professional advice or referral. Discussions concerning drugs, dosages, and procedures may reflect the clinical experience of the author(s) or they may be derived from the professional literature or other sources and may suggest uses that are investigational in nature and not approved labeling or indications. Participants are encouraged to refer to primary references or full prescribing information resources.
For questions about this internet CPE activity, please contact:
[email protected]
Privacy Policy and Terms of Use Information:
www.pharmacytimes.org/terms